ARTICLE SUMMARY:
As medtech stakeholders debate the best ways to design and implement more cost effective, pragmatic, and patient-centric clinical trials, one recent digital health study that remotely screened high-risk individuals for undiagnosed atrial fibrillation could help provide a roadmap for the future.
The mHealth Screening to Prevent Strokes (mSToPS) trial is one of the first large, randomized screening trials conducted entirely remotely using a digital wearable device—in this case an ECG monitoring patch.
